Zepbound vs. Wegovy: Breaking Down the SURMOUNT-5 Trial Results

Video will be live on Monday, May 19 at 1:00 PM Central Time. 

▪️ Join my channel to get access to perks or simply subscribe and turn on your notifications!
▪️ Download my FREE GLP-1/GIP Medication Information Sheet and 7-Day Best Weight Journal here.
▪️ Join my Empowerment Hub and discover sustainable, evidence-based solutions to transform your health and embrace self-care without guilt.
Your first 7 days are FREE—no risk, no commitment! After that, it’s just $15/month or $145/year!

Breaking Down the SURMOUNT-5 Trial: Zepbound vs. Wegovy for Weight Loss

Did you ever think the student would beat the teacher? Because in the SURMOUNT-5 trial, Tirzepatide (Zepbound) didn’t just match Semaglutide (Wegovy)—it outperformed it. We’re talking more weight loss, smaller waistlines, better tolerability, and clinical outcomes that have the obesity medicine world buzzing. 

This wasn’t just another pharma puff piece either—this was a superiority trial, meaning they put Zepbound head-to-head with Wegovy and asked the bold question: can it do better? 

Spoiler alert—it did.

In this video, I walk through the actual numbers, including average weight loss, categorical data, side effect profiles, and cardiometabolic improvements. I also break down the limitations—like open-label bias—and highlight a few curious findings that might make you raise an eyebrow. 

And for those of you who want the real story behind the data (the stuff you won’t find in the press release), I’ve included bonus content just for my OG Members where I unpack what might’ve tilted the playing field.

Thanks for watching and always remember: small tweaks lead to massive peaks!

References: 
Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Gomez Valderas E, Das S, Lee CJ, Glass LC, Senyucel C, Dunn JP; SURMOUNT-5 Trial Investigators. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. N Engl J Med. 2025 May 11. PMID: 40353578.

Don’t forget to hit the subscribe button for more insightful content, and consider joining our YouTube Members Membership for exclusive content and early access to weekly videos. 

📺 Watch These Next:
▪️ Watch This Before Taking Mounjaro
▪️ From Ozempic to Mounjaro
▪️ Muscle Loss with Ozempic, Wegovy & Mounjaro
▪️ Managing Nausea from Ozempic, Wegovy and Trulicity!
▪️ Ozempic: Stomach Paralysis Update
▪️ How to Switch from Ozempic (or Wegovy) to Mounjaro
▪️ Ozempic Paralyzed My Stomach
▪️ How to Inject Mounjaro: step-by-step tutorial

🎯 Free Resources:
▪️ GLP-1/GIP Medication Info Sheet + 7-Day Food Journal
▪️ Total Daily Energy Expenditure (TDEE) Calculator – Find your optimal calorie intake


🛒 Recommended Products for Your Weight-Loss Journey:
▪️ Managing Constipation
▪️ Managing Heartburn
▪️ Protein Bars & Supplements
▪️ Activity Trackers & Scales

Live in Alberta? Come see me at my Pharmacist-led Obesity Clinic at Apothecare Pharmacy – http://apothecarerx.ca 

 

Dr. Dan

Follow me on social media for regular updates – @TheOfficialDrDan

Subscribe to my newsletter for a heads-up on all new content.

Sharing is caring! Here’s the social, email, and even text link –
https://healthevolved.co/surmount-5

If you need some coaching support on your weight management journey, you can book a consultation with me to see if you’d be a good fit for our program. 

Questions or comments? Please send them my way on our Contact Us page!

Share:

More Posts

The Retatrutide Paradox: Why This “Triple Threat” Works

Retatrutide is a triple-action therapy targeting GLP-1, GIP, and glucagon receptors simultaneously — a fundamentally different design from current treatments. Early clinical data reveals significant liver-fat reductions and an unexpected paradox: a receptor long assumed to raise blood sugar instead helps mobilize stored fat and support resting metabolism.

Retatrutide TRIUMPH-1 Results: 28% Weight Loss

TRIUMPH-1 Phase 3 trial data reveals retatrutide achieved up to 30% body weight loss — outperforming bariatric surgery benchmarks without a single incision. I’m breaking down the full efficacy numbers, safety signals, and what this triple-hormone agonist means for your weight management options right now.

Slow Weight Loss on GLP-1s? This Is Why

Most people on Wegovy aren’t rapid responders — and the viral 28% weight loss headline from the STEP UP trial only tells half the story. Learn my 4-step Steady-Winner Strategy designed for the 70% who are playing the long game.

Your #1 Mistake When Taking Ozempic

Discover why the most common weight loss approach — cutting calories, carbs, and joy — is actually triggering your brain’s ancient famine alarm and working against your GLP-1 medication. I break down my counterintuitive Stack & Add Plan: five steps that work with your biology to protect muscle, outsmart metabolic adaptation, and finally walk through the door your medication opened.

Send Us A Message

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.

Try My New Calorie Calculator!

Calculate your daily calorie and protein targets to help you achieve your weight goals.